Holobiome Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10M
- Investors
-
26
Holobiome General Information
Description
Developer of a biotechnology platform designed to discover and develop therapies from the human microbiome. The company's platform offers research-driven microbiome analysis to identify beneficial and harmful microbial strains, probiotic formulation to create customized supplements and therapeutic products, and targeted health interventions to support gut health, metabolic balance, and immune system function, enabling healthcare professionals and patients to improve whole-body health and address complex medical challenges.
Contact Information
Website
www.holobiome.orgCorporate Office
- 650 Albany Street
- Boston, MA 02118
- United States
Corporate Office
- 650 Albany Street
- Boston, MA 02118
- United States
Holobiome Timeline
Holobiome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. Later Stage VC | 22-Jul-2026 | $10M | Completed | Generating Revenue | ||
| 19. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 18. Seed Round | 09-Oct-2024 | Completed | Generating Revenue | |||
| 17. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 16. Accelerator/Incubator | 04-Mar-2024 | Completed | Generating Revenue | |||
| 15. Grant | 28-Oct-2021 | Completed | Generating Revenue | |||
| 14. Grant | 24-Sep-2021 | Completed | Generating Revenue | |||
| 13. Grant | 24-Sep-2021 | Completed | Generating Revenue | |||
| 12. Seed Round | 11-Feb-2021 | $825K | $2.11M | Completed | Generating Revenue | |
| 11. Grant | 01-Nov-2020 | $500K | $1.28M | Completed | Generating Revenue |
Holobiome Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed-2 | ||||||||
| Seed-3 | 488,402 | $0.000100 | $1.91 | $1.91 | 1x | $1.91 | 3.64% | |
| Seed-4 | 927,913 | $0.000100 | $1.43 | $1.43 | 1x | $1.43 | 6.92% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Holobiome Patents
Holobiome Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026055454-A1 | Inactivated bacteroides bacteria and methods of use thereof | Pending | 05-Sep-2024 | ||
| WO-2025184340-A1 | Prebiotic combinations | Pending | 27-Feb-2024 | ||
| AU-2020308897-A1 | Therapeutic compositions and methods of using serotonin modulating microbiome-based interventions to treat serotonin-related diseases or disorders | Pending | 27-Jun-2019 | ||
| CA-3144072-A1 | Therapeutic compositions and methods of using serotonin modulating microbiome-based interventions to treat serotonin-related diseases or disorders | Pending | 27-Jun-2019 | ||
| EP-3989992-A2 | Therapeutic compositions and methods of using serotonin modulating microbiome-based interventions to treat serotonin-related diseases or disorders | Pending | 27-Jun-2019 | A61K35/745 |
Holobiome Signals
Holobiome Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Plug and Play | Accelerator/Incubator | |||
| Able Partners | Venture Capital | Minority | ||
| Astanor | Impact Investing | Minority | ||
| Bantam Group | Angel Group | Minority | ||
| Bluebirds Capital | Venture Capital | Minority |
Holobiome Acquisitions (1)
Holobiome’s most recent deal was a Merger/Acquisition with AsiaBiome. The deal was made on 01-Sep-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AsiaBiome | 01-Sep-2022 | Merger/Acquisition | Drug Discovery |
Holobiome FAQs
-
When was Holobiome founded?
Holobiome was founded in 2015.
-
Where is Holobiome headquartered?
Holobiome is headquartered in Boston, MA.
-
What is the size of Holobiome?
Holobiome has 20 total employees.
-
What industry is Holobiome in?
Holobiome’s primary industry is Drug Discovery.
-
Is Holobiome a private or public company?
Holobiome is a Private company.
-
What is Holobiome’s current revenue?
The current revenue for Holobiome is .
-
How much funding has Holobiome raised over time?
Holobiome has raised $11.2M.
-
Who are Holobiome’s investors?
Plug and Play, Able Partners, Astanor, Bantam Group, and Bluebirds Capital are 5 of 26 investors who have invested in Holobiome.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process